Highlights and Quick Summary
- Net Income Common for the quarter ending December 31, 2022 was $-5.41 Million (a 6.24% increase compared to previous quarter)
- Year-over-year quarterly Net Income Common increased by 65.22%
- Annual Net Income Common for 2022 was $-18.2 Million (a -0.0% decrease from previous year)
- Annual Net Income Common for 2022 was $-18.2 Million (a 31.16% increase from previous year)
- Annual Net Income Common for 2021 was $-13.9 Million (a -0.0% decrease from previous year)
- Twelve month Net Income Common ending December 31, 2022 was $-18.8 Million (a 3.23% increase compared to previous quarter)
- Twelve month trailing Net Income Common increased by 9.93% year-over-year
Trailing Net Income Common for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| $-18.8 Million | $-18.3 Million | $-18.2 Million | $-17.1 Million |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Income Common of Benitec Biopharma Limited
Most recent Net Income Commonof BNTC including historical data for past 10 years.Interactive Chart of Net Income Common of Benitec Biopharma Limited
Benitec Biopharma Limited Net Income Common for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $-5.41 | $-5.09 | $-5.07 | $-3.28 | $-18.21 |
| 2021 | $-4.82 | $-5.05 | $-4.0 | $-3.91 | $-13.88 |
| 2020 | $-3.25 | $-2.72 | $-2.94 | $-2.1 | $-8.27 |
| 2019 | – | – | $-2.09 | $-1.15 | $2.61 |
| 2018 | – | – | – | – | $-9.02 |
| 2017 | – | – | – | $-2.27 | $-4.29 |
| 2016 | – | – | – | $0.56 | $-18.05 |
| 2015 | – | – | – | – | $-9.64 |
| 2014 | – | – | – | – | $-6.46 |
| 2013 | – | – | – | – | $-3.58 |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology